ISBN: 9780470281741
The science and applied approaches of enzyme inhibition in drug discovery and development Offering a unique approach that includes both the pharmacologic and pharmaco-kinetic aspects of e… Mehr…
BarnesandNoble.com new in stock. Versandkosten:zzgl. Versandkosten. Details... |
ISBN: 9780470281741
Hardback, [PU: John Wiley & Sons Inc], This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pha… Mehr…
BookDepository.com Versandkosten:Versandkostenfrei. (EUR 0.00) Details... |
ISBN: 9780470281741
Hardback, [PU: John Wiley & Sons Inc], This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pha… Mehr…
BookDepository.com Versandkosten:Versandkostenfrei. (EUR 0.00) Details... |
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad - gebunden oder broschiert
2010, ISBN: 9780470281741
Wiley, 2010-01-07. Hardcover. Good., Wiley, 2010-01-07, 2.5
Biblio.co.uk |
2009, ISBN: 9780470281741
The Good and the Bad, Hardcover, Buch, [PU: John Wiley & Sons Inc]
lehmanns.de Versandkosten:Versand in 10-15 Tagen, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad Chuang Lu Editor - neues Buch
ISBN: 9780470281741
The science and applied approaches of enzyme inhibition in drug discovery and development Offering a unique approach that includes both the pharmacologic and pharmaco-kinetic aspects of e… Mehr…
ISBN: 9780470281741
Hardback, [PU: John Wiley & Sons Inc], This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pha… Mehr…
ISBN: 9780470281741
Hardback, [PU: John Wiley & Sons Inc], This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pha… Mehr…
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad - gebunden oder broschiert
2010, ISBN: 9780470281741
Wiley, 2010-01-07. Hardcover. Good., Wiley, 2010-01-07, 2.5
2009, ISBN: 9780470281741
The Good and the Bad, Hardcover, Buch, [PU: John Wiley & Sons Inc]
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Detailangaben zur CD - Enzyme Inhibition in Drug Discovery and Development
EAN (ISBN-13): 9780470281741
ISBN (ISBN-10): 047028174X
Gebundene Ausgabe
Erscheinungsjahr: 2010
Herausgeber: John Wiley & Sons Inc
854 Seiten
Gewicht: 1,270 kg
Sprache: eng/Englisch
CD in der Datenbank seit 2010-08-19T12:13:25+02:00 (Berlin)
Detailseite zuletzt geändert am 2022-02-01T11:38:54+01:00 (Berlin)
EAN: 9780470281741
EAN - alternative Schreibweisen:
0-470-28174-X, 978-0-470-28174-1
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor der CD: chuang, chuan
Titel der CD: enzyme, development inhibition, the enzymes
Daten vom Verlag:
Autor/in: Chuang Lu; Albert P. Li
Titel: Enzyme Inhibition in Drug Discovery and Development - The Good and the Bad
Verlag: John Wiley & Sons
868 Seiten
Erscheinungsjahr: 2010-01-26
Gewicht: 1,274 kg
Sprache: Englisch
195,00 € (DE)
Not available (reason unspecified)
165mm x 240mm x 43mm
BB; GB; Hardcover, Softcover / Chemie; Chemie; Pharmakologie u. Pharmazeutische Medizin; Drug Discovery & Development; Enzymes & Receptors; Medical Science; Enzyme u. Rezeptoren; Wirkstoffforschung u. -entwicklung; Enzyme; Chemistry; Medizin; Wirkstoffforschung; Pharmacology & Pharmaceutical Medicine; Chemie; Pharmakologie
PREFACE. CONTRIBUTORS. PART I. DRUG DISCOVERY APPROACHES AND TECHNOLOGIES. 1. The Drug Discovery Process (Gerald T. Miwa). 2. Medicinal Chemistry of the Optimization of Enzyme Inhibitors (Geraldine Harriman, Amy Elder, and Indranath Ghosh). 3. Bioanalytical Technologies in Drug Discovery (Jing-Tao Wu). 4. Safety Biomarkers in Drug Development: Emerging Trends and Implications (Eric R. Fedyk). 5. The Role of Drug Metabolism in Drug Discovery (Tonika Bohnert and Liang-Shang Gan). 6. Applied Pharmacokinetics in Drug Discovery and Development (Hua Yang, Xingrong Liu, Anjaneya Chimalakonda, Zheng Lu, Cuiping Chen, Frank Lee, and Wen Chyi Shyu). PART II. INHIBITION OF THE DRUG METABOLIZING ENZYMES--THE UNDESIRABLE INHIBITION. 7. Enzyme Inhibition and Inactivation: Cytochrome P450 Enzymes (R. Scott Obach). 8. Cytochrome P450 Induction (Edward L. LeCluyse, Michael W. Sinz, Nicola Hewitt, Stephen S. Ferguson, and Jasminder Sahi). 9. Inhibition of Drug-Metabolizing Enzymes in Gastrointestinal Tract and Its Influence on the Drug-Drug Interaction Prediction (Aleksandra Galetin and J. Brian Houston). 10. Enzyme Inhibition in Various In Vitro Systems (Ping Zhou). 11. Cytochrome P450 Degradation and Its Clinical Relevance (Mingxiang Liao, Ping Kang, Bernard P. Murray, and Maria Almira Correia). 12. Complexities of Working with UDP-Glucuronosyltransferases (UGTs): Focus on Enzyme Inhibition (Michael B. Fisher). 13. Evaluation of Inhibitors of Drug Metabolism in Human Hepatocytes (Albert P. Li and Chuang Lu). 14. Grapefruit Juice and Its Constituents as New Esterase Inhibitors (Suresh K. Balani). 15. Transporter-Xenobiotic Interactions: An Important Aspect of Drug Development Studies (Gang Luo, Richard Ridgewell, and Thomas Guenthner). 16. Polymorphisms of Drug Transporters and Their Clinical Implications (Cindy Q. Xia and Johnny J. Yang). 17. Clinical Drug Interactions Due to Metabolic Inhibition: Prediction, Assessment, and Interpretation (Lisa L. von Moltke and David J. Greenblatt). 18. Predicting Interindividual Variability of Metabolic Drug-Drug Interactions: Identifying the Causes and Accounting for Them Using Systems Approach (Amin Rostami-Hodjegan). PART III. INHIBITION OF THE DRUG TARGET ENZYMES--THE DESIRABLE INHIBITION. 19. NF-ºB: Mechanism, Tumor Biology, and Inhibitors (Lenny Dang). 20. G-Protein-Coupled Receptors as Drug Targets (Wenyan Miao and Lijun Wu). 21. Pharmacological Modulation of Ion Channels for the Treatment of Chronic Pain (Yi Liu and Ning Qin). 22. Targeting the mTOR Pathway for Tumor Therapeutics (Wei Chen). 23. HIV-1 Protease Inhibitors as Antiretroviral Agents (Sergei V. Gulnik, Elena Afonina, and Michael Eissenstat). INDEX.Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9780470538944 Enzyme Inhibition in Drug Discovery and Development (Chuang Lu; Albert P. Li)
< zum Archiv...